Inventor · disambiguated record
Thomas Peter Matthews
Also filed as: MATTHEWS THOMAS · MATTHEWS THOMAS PETER
14 granted patents·2 pending applications·91 citations·filing 2004–2023
92Inventor score
Files withVERNALIS R&D LTD4CANCER RES TECH LTD3CANCER REC TECH LTD2CANCER RESEARCH TECH LTD2DRYSDALE MARTIN JAMES2
Top patents by PatentIndex Score
16 records- 0193US8367658B2Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their useCANCER REC TECH LTD·Filed 2011·Granted Feb 5, 2013·16 cites·19 claims
- 0293US8058045B2Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their useCOLLINS IAN·Filed 2008·Granted Nov 15, 2011·22 cites·20 claims
- 0392US9765059B25-(Pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic useCANCER RES TECH LTD·Filed 2016·Granted Sep 19, 2017·6 cites·20 claims
- 0491US9403797B25-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic useCANCER RES TECH LTD·Filed 2015·Granted Aug 2, 2016·6 cites·38 claims
- 0586US8507480B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2010·Granted Aug 13, 2013·8 cites·30 claims
- 0684US8450310B2Isoxazole compounds as inhibitors of heat shock proteinsDRYSDALE MARTIN JAMES·Filed 2012·Granted May 28, 2013·6 cites·29 claims
- 0783US11787792B25-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereofCANCER RESEARCH TECH LTD·Filed 2020·Granted Oct 17, 2023·1 cites·21 claims
- 0882US10413550B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2017·Granted Sep 17, 2019·2 cites·28 claims
- 0981US9663503B25-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereofCANCER RES TECH LTD·Filed 2013·Granted May 30, 2017·5 cites·19 claims
- 1080US9718793B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2013·Granted Aug 1, 2017·3 cites·29 claims
- 1178US10259806B25-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereofCANCER RESEARCH TECH LTD·Filed 2017·Granted Apr 16, 2019·2 cites·16 claims
- 1277US7705027B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS CAMBRIDGE LTD·Filed 2004·Granted Apr 27, 2010·7 cites·34 claims
- 1376US11234987B2Isoxazole compounds as inhibitors of heat shock proteinsVERNALIS R&D LTD·Filed 2019·Granted Feb 1, 2022·0 cites·29 claims
- 1475US9040540B25-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic useCANCER REC TECH LTD·Filed 2012·Granted May 26, 2015·7 cites·39 claims
- 1561US2025084074A1Substituted heterocycles as hset inhibitorsMERCK PATENT GMBH·Filed 2023·Application pending·0 cites
- 1646US2009054421A1Pyrimidothiophene Compounds Having HSP90 Inhibitory ActivityVERNALIS R&D LTD·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →